|
|
|
|
LEADER |
01091nam a2200265 u 4500 |
001 |
EB000942715 |
003 |
EBX01000000000000000736305 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
150223 r ||| eng |
020 |
|
|
|a 1860162827
|
020 |
|
|
|a 9781860162824
|
245 |
0 |
0 |
|a Atrial fibrillation
|h Elektronische Ressource
|b national clinical guideline for management in primary and secondary care
|c National Collaborating Centre for Chronic Conditions
|
260 |
|
|
|a London
|b Royal College of Physicians
|c 2006, c2006
|
300 |
|
|
|a x, 173 p.
|b ill
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Atrial Fibrillation / therapy
|
653 |
|
|
|a United Kingdom
|
653 |
|
|
|a Fibrinolytic Agents / therapeutic use
|
710 |
2 |
|
|a National Collaborating Centre for Chronic Conditions (Great Britain)
|
710 |
2 |
|
|a Royal College of Physicians of London
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK51113
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|